Clinical Trials - Patent Laws
The government of India passed a Patent Law in 1970, recognizing only patents on processes and not products , thus enabling pharmaceutical companies to use alternative methods to produce cheap " generic " copies of
After joining with the World Trade Organization in 1995 India made changes in its patent law again and brought it in line with International laws in January 2005. This new bill recognizes both product and process patents. According to the law India will also offer 10-year tax concessions on revenue to companies making Research & Development (R& D) investments in India . These incentives are envisaged to cause a substantial boost and increase in R&D activities of both Multinational and Indian Pharmaceutical companies.
Please use one of the following formats to cite this article in your essay, paper or report:
Vanessa Jones. (2016, April 22). Clinical Trials - Patent Laws . Medindia. Retrieved on Jul 02, 2022 from https://www.medindia.net/patients/patientinfo/clinical_patent.htm.
Vanessa Jones. "Clinical Trials - Patent Laws ". Medindia. Jul 02, 2022. <https://www.medindia.net/patients/patientinfo/clinical_patent.htm>.
Vanessa Jones. "Clinical Trials - Patent Laws ". Medindia. https://www.medindia.net/patients/patientinfo/clinical_patent.htm. (accessed Jul 02, 2022).
Vanessa Jones. 2021. Clinical Trials - Patent Laws . Medindia, viewed Jul 02, 2022, https://www.medindia.net/patients/patientinfo/clinical_patent.htm.